Point-of-care Diagnostics

The assay format determines which biological signal the device measures. Antigen detection and immunoassays identify biological targets through specific molecular interactions, nucleic acid amplification evaluates genetic material, and electrochemical biosensors convert biological recognition into an electrical readout. Selecting among these approaches connects the sample type and clinical question with the information needed for an immediate decision.

Sample type affects which biological information can be accessed and how conveniently testing can occur near the patient. Blood, saliva, urine, and swabs can support different analyses, including infectious-disease detection or physiological-marker monitoring. Matching the specimen to the intended measurement helps the test address the relevant clinical question without requiring every sample to undergo the same workflow.

Their main distinction is where and when information becomes available. Performing analysis near the patient can shorten the interval between sample collection and a clinical decision, while portability supports testing in clinics, homes, and resource-limited settings. This changes the role of testing from a delayed laboratory result to information that can guide immediate intervention or follow-up.

A typical workflow begins with collecting an appropriate biological sample, such as blood, saliva, urine, or a swab. The sample is then analyzed with a disposable device or compact instrument using an assay such as antigen detection, nucleic acid amplification, an immunoassay, or an electrochemical biosensor. The resulting information can be considered alongside the patient’s clinical situation.

They are especially useful when a rapid result can influence what happens next. Applications include detecting infectious diseases, monitoring physiological markers, and assessing responses to treatment. Because testing occurs near the patient, clinicians or other users can obtain relevant information without depending entirely on a centralized laboratory, supporting timely decisions across clinics, homes, and resource-limited settings.

Point-of-care diagnostics can extend testing beyond centralized facilities by bringing biological measurement into clinics, homes, and resource-limited settings. Rapid information about infectious diseases can support recognition of cases and strengthen disease surveillance, while measurements of physiological markers or treatment responses provide additional insight into health status. Their portability therefore links individual testing with broader monitoring efforts.